Search results
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 2 days agoVerastem gained an exclusive wordwide licence for avutometinib from Chugai Pharmaceuticals in...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 5 days agoWelford forecasts more than $9 billion in peak sales for datopotamab deruxtecan, which is part of a partnership with Daiichi Sankyo. Executives are...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoWhile these three stocks gained notoriety back in 2020 during the COVID-19 pandemic, it appears this week's detection of avian bird flu in a second...of...
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 6 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 2 days agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 6 days agoModerna CEO Stéphane Bancel recently told Barron’s that launching the shots in August instead of...
JD Supra: Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.
JD Supra· 16 hours agoPharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. The majority opinion raises issues in its invalidity analysis regarding the extent to which the prior art should be required to disclose ...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoThis month, the company announced it was pulling the vaccine off the market globally, citing a decline in demand. The association between the AstraZeneca COVID-19 vaccine and a rare and dangerous ...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 1 day agoShaowen Bao, a University of Arizona professor, and Robert Edmonds, a COVID-19 vaccine patient from New Mexico. “It’s very difficult when you have a very sudden event, and you're trying to get ...
Why This Biotech Just Launched — Again — After Its 166% Run
Investor's Business Daily· 6 days agoDyne studied drugs it calls DYNE-101 and DYNE-251 in patients with myotonic dystrophy type 1 and...